121 related articles for article (PubMed ID: 9027167)
1. [The characterization of Francisella tularensis mutants and subspecies by using monoclonal antibodies].
Aleshkin GI; Efanova EA; Komissarova LV; Kozlovskiĭ VN; Rozhkov EV; Zakharenko VI
Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):18-22. PubMed ID: 9027167
[TBL] [Abstract][Full Text] [Related]
2. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
[TBL] [Abstract][Full Text] [Related]
4. [The determination of the antigenic determinant of protective monoclonal antibodies specific to the Francisella tularensis lipopolysaccharide].
Khlebnikov VS; Golovlev IR; Tokhtamysheva NV; Averin SF; Kulevatskiĭ DP; Grechko GK; Averina AA; Vetchinin SS
Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):83-8. PubMed ID: 7520655
[TBL] [Abstract][Full Text] [Related]
5. Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis.
Bhatti AR; Wong JP; Woods DE
Hybridoma; 1993 Apr; 12(2):197-202. PubMed ID: 7686137
[TBL] [Abstract][Full Text] [Related]
6. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
7. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
[TBL] [Abstract][Full Text] [Related]
8. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body].
Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638
[TBL] [Abstract][Full Text] [Related]
9. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.
Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL
Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846
[TBL] [Abstract][Full Text] [Related]
10. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis.
Hotta A; Uda A; Fujita O; Tanabayashi K; Yamada A
Clin Vaccine Immunol; 2007 Jan; 14(1):81-4. PubMed ID: 17121981
[TBL] [Abstract][Full Text] [Related]
11. Differential Substrate Usage and Metabolic Fluxes in
Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
[No Abstract] [Full Text] [Related]
12. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteome analysis of cellular proteins extracted from highly virulent Francisella tularensis ssp. tularensis and less virulent F. tularensis ssp. holarctica and F. tularensis ssp. mediaasiatica.
Hubálek M; Hernychová L; Brychta M; Lenco J; Zechovská J; Stulík J
Proteomics; 2004 Oct; 4(10):3048-60. PubMed ID: 15378745
[TBL] [Abstract][Full Text] [Related]
14. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
15. ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication.
Alam A; Golovliov I; Javed E; Sjöstedt A
Sci Rep; 2018 Jul; 8(1):11324. PubMed ID: 30054549
[TBL] [Abstract][Full Text] [Related]
16. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reacting specifically with Francisella sp.
Greiser-Wilke I; Soiné C; Moennig V
Zentralbl Veterinarmed B; 1989 Oct; 36(8):593-600. PubMed ID: 2596200
[TBL] [Abstract][Full Text] [Related]
18. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
19. Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo.
Straskova A; Spidlova P; Mou S; Worsham P; Putzova D; Pavkova I; Stulik J
Pathog Dis; 2015 Nov; 73(8):ftv058. PubMed ID: 26253078
[TBL] [Abstract][Full Text] [Related]
20. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
